Trevi Therapeutics Announces Fourth Quarter and Year End 2021 Financial Results and Business Update

Go back to Trevi Therapeutics Announces Fourth Quarter and Year End 2021 Financial Results and Business Update

Trevi Therapeutics (TRVI) Tops Q4 EPS by 2c

March 17, 2022 4:13 PM EDT

Trevi Therapeutics (NASDAQ: TRVI) reported Q4 EPS of ($0.28), $0.02 better than the analyst estimate of ($0.30).

For earnings history and earnings-related data on Trevi Therapeutics (TRVI) click here.

... More